Skip to main content

Peer Review reports

From: Effect of degalactosylated bovine glycoprotein formulations MAF and M сapsules on lymphopenia and clinical outcomes in hospitalized COVID-19 patients: a randomized clinical trial

Original Submission
29 Apr 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
25 Sep 2023 Reviewed Reviewer Report - Jean-François Rossi
29 Sep 2023 Reviewed Reviewer Report - Mehdi Hassaniazad
12 Oct 2023 Reviewed Reviewer Report
15 Nov 2023 Author responded Author comments - Galyna Kutsyna
Resubmission - Version 3
15 Nov 2023 Submitted Manuscript version 3
15 Nov 2023 Author responded Author comments - Galyna Kutsyna
Resubmission - Version 4
15 Nov 2023 Submitted Manuscript version 4
15 Dec 2023 Reviewed Reviewer Report - Jean-François Rossi
22 Dec 2023 Reviewed Reviewer Report
19 Jan 2024 Author responded Author comments - Galyna Kutsyna
Resubmission - Version 5
19 Jan 2024 Submitted Manuscript version 5
1 Feb 2024 Reviewed Reviewer Report
22 Feb 2024 Author responded Author comments - Galyna Kutsyna
Resubmission - Version 6
22 Feb 2024 Submitted Manuscript version 6
22 Mar 2024 Reviewed Reviewer Report
2 Apr 2024 Author responded Author comments - Galyna Kutsyna
Resubmission - Version 7
2 Apr 2024 Submitted Manuscript version 7
Publishing
3 Apr 2024 Editorially accepted
23 May 2024 Article published 10.1186/s12879-024-09286-0

You can find further information about peer review here.

Back to article page